ERC Society for Endocrinology Archive
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Endocrine-Related Cancer 13 (3) 963 -970     DOI: 10.1677/erc.1.01201
Copyright © 2006 by the Society for Endocrinology
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (6)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ekeblad, S.
Right arrow Articles by Skogseid, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ekeblad, S.
Right arrow Articles by Skogseid, B.

Gastrointestinal stromal tumors express the orexigen ghrelin

Sara Ekeblad, Bengt Nilsson1, Margareta Halin Lejonklou, Térèse Johansson, Peter Stålberg2, Ola Nilsson3, Håkan Ahlman1 and Britt Skogseid

Department of Medical Sciences, University Hospital, 75185 Uppsala, Sweden
1 Department of Surgery, Sahlgrenska University Hospital, 41345 Göteborg, Sweden
2 Department of Surgical Sciences, University Hospital, 75185 Uppsala, Sweden
3 Department of Pathology, Sahlgrenska University Hospital, 41345 Göteborg, Sweden

(Requests for offprints should be addressed to B Skogseid; Email: britt.skogseid{at}medsci.uu.se)

Expression of the neuroendocrine marker synaptic vesicle protein 2 (SV2) has been reported in a few cases of gastrointestinal stromal tumors (GISTs). The goal of the present study was to assess the relevance of this finding and identify a possible hormone production in these tumors. We chose to study the orexigen ghrelin and its receptor, since these patients are seldom cachexic, even in advanced disease stages. We investigated ghrelin expression by means of immunohistochemistry on frozen or paraffin-embedded sections from 22 GISTs from a well-characterized patient material. Expression of the growth hormone secretagogue receptor, the ghrelin receptor, was investigated in a subset of lesions. In six tumors, mRNA levels of ghrelin, the ghrelin receptor, and SV2 were analyzed by real-time quantitative PCR. Totally 17 out of 22 tumors showed immunoreactivity for ghrelin. Five out of ten tumors were immunoreactive for the ghrelin receptor, and all of these co-expressed ghrelin. All tumors expressed ghrelin, ghrelin receptor, and SV2 mRNA. GISTs frequently express SV2, ghrelin, and its receptor, indicating the presence of autocrine/paracrine loops.




This article has been cited by other articles:


Home page
BMJHome page
H Kahal, E Cooper, R Sriraman, and D V Coppini
A woman with a suprarenal mass and hypertension
BMJ, March 4, 2009; 338(mar04_2): b333 - b333.
[Full Text]


Home page
Endocr Relat CancerHome page
P. Bumming, O. Nilsson, H. Ahlman, A. Welbencer, M. K Andersson, K. Sjolund, and B. Nilsson
Gastrointestinal stromal tumors regularly express synaptic vesicle proteins: evidence of a neuroendocrine phenotype
Endocr. Relat. Cancer, September 1, 2007; 14(3): 853 - 863.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the Society for Endocrinology.